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Summary
Mutations in the retinal-expressed gene CRX (cone-rod
homeobox gene) have been associated with dominant
cone-rod dystrophy and with de novo Leber congenital
amaurosis. However, CRX is a transcription factor for
several retinal genes, including the opsins and the gene
for interphotoreceptor retinoid binding protein. Because
loss of CRX function could alter the expression of a
number of other retinal proteins, we screened for mu-
tations in the CRX gene in probands with a range of
degenerative retinal diseases. Of the 294 unrelated in-
dividuals screened, we identified four CRX mutations
in families with clinical diagnoses of autosomal domi-
nant cone-rod dystrophy, late-onset dominant retinitis
pigmentosa, or dominant congenital Leber amaurosis
(early-onset retinitis pigmentosa), and we identified four
additional benign sequence variants. These findings im-
ply that CRX mutations may be associated with a wide
range of clinical phenotypes, including congenital retinal
dystrophy (Leber) and progressive diseases such as cone-
rod dystrophy or retinitis pigmentosa, with a wide range
of onset.
Introduction
Inherited retinal diseases are exceptionally heterogene-
ous, both genetically and phenotypically. A total of 96
genes causing inherited retinal diseases have been
mapped to chromosomal sites in man, but less than half
have been cloned (RetNet; Daiger et al. 1998). Not only
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is the diagnosis of some of these diseases difficult because
of overlapping phenotypes, but mutations within a single
gene may cause very different phenotypes. For example,
different mutations in one gene, peripherin/RDS, have
been associated with several forms of retinal degenera-
tion, such as cone-rod dystrophy, cone degeneration, and
retinitis pigmentosa, affecting both the macula and the
panretinal structures (Weleber et al. 1993; Wells et al.
1993; Keen et al. 1994; Nakazawa et al. 1994, 1996).
Recently, mutations within the photoreceptor-ex-
pressed gene CRX (cone-rod homeobox gene; MIM
120970) have been reported to cause dominant cone-
rod dystrophy at the CORD2 locus (Freund et al. 1997;
Swain et al. 1997); in addition, de novo CRX mutations
have been found in isolated cases of Leber congenital
amaurosis (Freund et al. 1998). CRX belongs to the
orthodenticle homeobox (OTX) family of homeobox
genes, members of which are involved in the develop-
ment of anterior head structures and other embryonic
features (Finkelstein and Boncinelli 1994). The three ex-
ons of CRX encode a 299–amino acid polypeptide,
which shows a high degree of sequence similarity to
OTX and OTX-related homeodomain proteins: the
CRX homeobox sequence has up to 88% identity with
the homeobox sequences of other members of theOTX
gene family. In addition to the homeodomain, CRX and
the otherOTX-related genes share two highly conserved
peptide sequences, a 13–amino acid WSP motif and a
12–amino acid OTX tail (Furukawa et al. 1997; Swain
et al. 1997; Freund et al. 1998). CRX is also expressed
in the pineal gland and is a transcription factor for pin-
eal-specific genes (Li et al. 1998).
CRX binds specifically to conserved sequences up-
stream of several photoreceptor-specific genes, including
the opsins, and CRX activates transcription of inter-
photoreceptor retinoid binding protein, arrestin, and b-
phosphodiesterase (Chen et al. 1997; Furukawa et al.
1997). Because CRX appears to affect many retinal
genes, mutations within theCRX genemay be associated
with different retinal-disease phenotypes.
We screened theCRX gene in a large cohort of patients
with a wide range of clinical diagnoses (table 1). We
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Table 1
Clinical Diagnoses of Individuals Screened for CRX Mutations, in
This Study
Clinical Diagnosis
No. of Unrelated
Probands Tested
Retinitis pigmentosa, autosomal
dominant 164
Retinitis pigmentosa, autosomal
recessive 22
Retinitis pigmentosa, isolated 63
Cone-rod dystrophy or degeneration,
autosomal dominant 24
Rod-cone dystrophy, autosomal
dominant 6
Cone degeneration, autosomal dominant 6
Bardet-Biedl syndrome, autosomal
recessive 3
Leber congenital amaurosis, autosomal
dominant 1
Leber congenital amaurosis, isolated 1
Chorioretinitis, isolated 2
Usher syndrome, autosomal recessive 1
Optic atrophy, autosomal dominant 1
report a new CRX mutation associated with autosomal
dominant cone-rod dystrophy in one family and the
E80A mutation reported by Freund et al. (1997) in a
second, unrelated family with cone-rod dystrophy. The
present study also demonstrates association between
CRX mutations and a family with late-onset, autosomal
dominant retinitis pigmentosa or mild, atypical, cone-
rod dystrophy and a family with severe congenital cone-
rod dystrophy with the clinical description “dominant
Leber congenital amaurosis” (Heckenlively 1988). Clin-
ical summaries of the diseases in these families are pre-
sented, to emphasize the broad impact of CRX muta-
tions.
Subjects, Material, and Methods
Subjects
Subjects were ascertained at one of the following sites:
(1) the Anderson Vision Research Center, Retina Foun-
dation of the Southwest, Dallas (108 unrelated pro-
bands); (2) the Jules Stein Eye Institute, UCLA School
of Medicine, Los Angeles (167 unrelated probands); or
(3) the Hermann Eye Center, Department of Ophthal-
mology, The University of Texas Health Science Center,
Houston (19 unrelated probands, including the large
cone-rod dystrophy family from Texas). Informed con-
sent was obtained from all subjects. For each case, clin-
ical evaluation was by at least one of the coauthors and,
for several cases, by two coauthors jointly. Families in
which CRX mutations were found are shown in figures
1–4; individuals from whom DNA samples were ob-
tained and tested are indicated by “DNA” to the upper
right of the symbol.
DNA Isolation
DNA was isolated from peripheral blood by use of
the Puregene DNA extraction kit (Gentra), in accor-
dance with the manufacturer’s instructions.
Genotyping
Primer pairs for the chromosome 19 linkage markers
were obtained from Research Genetics. The forward-
strand primer was end labeled with 32P-ATP and poly-
nucleotide kinase (Promega). Amplified DNA was di-
luted 2:3 (vol:vol) with a solution of 95% formamide,
20 mM EDTA, 0.05% bromophenyl blue, and 0.05%
xylene cyanol, and fragments were separated on 6%
denaturing acrylamide gels (Promega).
SSCP Analysis
Genomic DNA samples from patients were screened
by SSCP, by use of five sets of primers (table 2). All
primers were synthesized by a commercial source (Geno-
sys Biotechnologies). PCR was performed with Ampli-
Taq polymerase (Perkin Elmer). Products were radio-
labeled by incorporation of 1 mCi 32P-dCTP. After an
initial denaturation step for 5 min at 95C, PCR was
conducted for 30 cycles, each with a denaturation step
of 30 s at 95C. Annealing was for 30 s at 64C for
fragments 1, 2, 3a, and 3b. Annealing for fragment 3c
was for 30 s at 60C. Extension for all fragments was
for 30 s at 72C, with a final elongation step for 10 min
at 72C. The amplified products for exons 1, 2, and 3a
were analyzed as described elsewhere by Freund et al.
(1997). In this study, the 3b fragment of Freund et al.
(1997) was amplified in two smaller independent and
overlapping fragments, 3b and 3c. The amplification
products of exon 3c were digested with EcoRI (Strata-
gene), yielding fragments of 209 bp and 132 bp for SSCP
analysis.
For SSCP, PCR products were denatured and sepa-
rated on a 0.6#MDE gel (FMC Bioproducts), either at
room temperature or at 4C. The gel was prepared in
0.6# Tris-borate EDTA buffer and was subjected to
autoradiography after electrophoresis.
Sequence Analysis
In general, for sequence analysis, the fragment show-
ing an SSCP variant was amplified, by PCR, from the
stock DNA for the patient. The fragment then was
treated with shrimp alkaline phosphatase (Amersham)
and exonuclease I (Amersham), followed by sequencing
with the AmpliCycle sequencing kit (Perkin Elmer) and
a primer end labeled with 33P-ATP. The PCR sequencing
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Figure 1 Family UTAD148, cone-rod dystrophy, autosomal dominant. Left, Pedigree. Blackened symbols represent affected individuals.
A question mark (?) designates an individual of unknown phenotype. “DNA” to the upper right of the symbol indicates that a DNA sample
was tested. Right, Sequence of exon 2, showing the ArC substitution in one allele (indicated by arrow), at nucleotide 238.
protocol consisted of a 2-min denaturation step at 95C,
followed by 30 cycles of 30 s at 95C and 30 s at 60C
each. The sequence was separated on 6% Long Ranger
(FMC) denaturing acrylamide gels.
For insertion or deletion mutations detected by PCR-
product sequencing, a second amplification of the frag-
ment was followed by subcloning with the PCR-Script
Amp Cloning kit (Stratagene). The fragment then was
sequenced by use of vector-specific primers, by the
SeqExpress automated sequencing laboratory of Re-
search Genetics. Exact sizes of deletions or insertions
were determined by comparison of the mutated sequence
with the wild-type sequence (GenBank cDNA accession
number AF024711).
The E80A mutation was assayed in all individuals
from family UTAD148, by amplification of CRX exon
2 followed by restriction digestion. CRX exon 2 was
amplified from patient genomic DNA, by PCR using the
conditions described above, and was digested withHinfI
(Stratagene) for 2 h at 37C. The enzyme was inactivated
with a final 10-min “soak” at 80C, and digested prod-
ucts were separated on a nondenaturing 2.5% agarose
gel stained with ethidium bromide. Fragments of 229
bp and 85 bp were observed for each normal allele, and
a fragment of 314 bp was observed for each mutant
allele.
Results
Of the 294 probands from unrelated families screened
for CRX mutation (table 1), we identified four disease-
associated mutations in families with inherited retinop-
athies and an additional four benign variants (table 3).
Of the 24 unrelated individuals from families with au-
tosomal dominant cone-rod dystrophy, 2 haveCRXmu-
tations. Of the 164 families with autosomal dominant
retinitis pigmentosa, 1 has a CRX mutation. Later anal-
ysis of additional members of the retinitis pigmentosa
family suggested an alternative diagnosis of late-onset,
atypical, cone-rod dystrophy. No CRX mutations were
observed in samples from pedigrees with isolated retinitis
pigmentosa or recessive retinitis pigmentosa. An addi-
tional CRX mutation was found in a family with au-
tosomal dominant Leber congenital amaurosis. These
mutations were not observed in any of the other un-
related individuals screened, in a total of 588 chro-
mosomes.
Family UTAD148, Cone-Rod Dystrophy, Autosomal
Dominant
Linkage of cone-rod dystrophy in a large family from
Texas, UTAD148 (fig. 1), to theCORD2 locus was dem-
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Figure 2 Family RFS014, cone-rod dystrophy, autosomal dom-
inant. Left, Pedigree. Blackened symbols represent affected individuals.
The symbol with a black bar represents an individual whose affected
status was determined by “hearsay.” “DNA” to the upper right of the
symbol indicates that a DNA sample was tested. Right, Results of
SSCP analysis of exon 3b, showing aberrantly migrating fragment in
the lane designated “m.”
Figure 3 Family RFS087, retinitis pigmentosa, autosomal dom-
inant. Left, Pedigree. Blackened symbols represent affected individuals.
“DNA” to the upper right of the symbol indicates that a DNA sample
was tested. Right, Sequence of exon 2, showing the ArG substitution
in one allele (indicated by arrow), at nucleotide 121.
onstrated by use of 10 microsatellite markers in the re-
gion, with a maximum LOD score of 7.14 at 0% re-
combination to D19S902 (Sohocki et al. 1997). Five
affected members of this family (fig. 1) were shown, by
SSCP analysis of CRX, to share a variant band in exon
2. Sequencing revealed an ArC transversion at codon
80 (fig. 1), resulting in an amino acid change from glu-
tamic acid to alanine (E80A). Because this sequence
change eliminates a HinfI restriction site, PCR amplifi-
cation of exon 2 followed by restriction with HinfI was
used to confirm that the E80A mutation was present in
all affected individuals ( ) and was lacking in alln  18
unaffected individuals ( ) available from thisn  17
family.
This is the same mutation reported, by Freund et al.
(1997), to be associated with cone-rod dystrophy in a
Greek family. To determine if the Texas and Greek fam-
ilies share a common ancestor with the mutation or if
the mutations in the two families arose independently,
haplotype analysis was performed. Two DNA samples
from affected members of the Greek family were com-
pared with those from the Texas family, by use of three
markers tightly linked to the CORD2 locus: D19S902,
D19S606, and D19S412 (Lawrence Livermore National
Laboratory; Sohocki et al. 1997). For each marker, the
allele shared by affected members of the Texas family
differed from that shared by affected members of the
Greek family (data not shown).
Family RFS014, Cone-Rod Dystrophy, Autosomal
Dominant
An affected member of this family (fig. 2) was shown,
by SSCP analysis, to have a variant band for exon 3b
(fig. 2). PCR-product sequencing suggested a 1-bp in-
sertion in codon 196 (Ala1961 bp). The fragment was
amplified and subcloned, and the clones were sequenced,
confirming the 1-bp insertion. The mutation was iden-
tified in an additional affected family member, by SSCP.
Family RFS087, Retinitis Pigmentosa (Late Onset with
Cone-Rod Involvement), Autosomal Dominant
One affected member of this family (fig. 3) was shown
to have an SSCP variant in exon 2. Sequencing revealed
a GrA transition in codon 41 (fig. 3), resulting in a
missense mutation substituting a glutamine for arginine
(R41Q). This mutation was confirmed, by SSCP, in two
additional affected family members and was absent from
an unaffected member (fig 3A). The R41Qmutation was
also reported by Swain et al. (1997), for a family with
cone-rod dystrophy.
Family RFS900, Leber Congenital Amaurosis (Early-
Onset Retinitis Pigmentosa), Autosomal Dominant
Two affected members of this family (fig. 4) were
shown, by SSCP analysis, to have a variant in the over-
lapping segment of exons 3a and 3b (fig. 4). PCR-prod-
uct sequencing suggested a 12-bp deletion beginning in
codon 146 (L146-12 bp). The deletion was confirmed
by subcloning genomic PCR products and by sequenc-
ing. The deletion also was observed in four additional
affected family members and was not observed in one
unaffected family member (fig. 4).
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Figure 4 Family RFS900, Leber congenital amaurosis, autosomal dominant. Left, Pedigree. Blackened symbols represent affected indi-
viduals. A question mark (?) designates an individual of unknown phenotype. “DNA” to the upper right of the symbol indicates that a DNA
sample was tested. Right, Results of SSCP analysis of exon 3a, showing aberrantly migrating fragments in the lanes designated “m.”
Apparently Benign Variants
In addition to the four disease-causing mutations, two
silent substitutions and two intronic variants were iden-
tified in this study. Three of the variants were observed
in the affected proband of one family each. The first is
a GrA transition in codon 183 (G183G), the second is
a CrT transition in codon 199 (S199S), and the third
is a GrA transition 15 bp upstream (5′) of the exon 3
coding sequence (IVS2-15GrA). No other family mem-
bers were available for testing whether the substitution
was cosegregating with the disease, in these families.
A fourth benign, intronic variant, an ArT transver-
sion 65 bp upstream (5′) of exon 2 (IVS1-65ArT), was
observed in affected members of six unrelated families.
In one family (with autosomal dominant cone-rod dys-
trophy), this substitution was present in one affected
individual but was not present in two other affected
family members.
One plausible mechanism by which an apparently be-
nign substitution may cause disease is through creation
of a cryptic splice site. However, no alternate RNA splice
site due to these substitutions was predicted by Mac-
Vector (Oxford Molecular Group). Also, silent substi-
tutions are well tolerated in vertebrates, and the two
intronic substitutions are far from the donor or acceptor
splice sites. For these reasons, it is very likely that these
are benign variants that do not contribute to the disease
phenotype.
Clinical Description of Families with CRX Mutations
Family UTAD148, Cone-Rod Dystrophy.—There is
complete penetrance in this large family with 132 af-
fected members (Mintz-Hittner et al. 1975). The affected
patients are symptomatic by age 8 years. Visual acuity
drops rapidly, from 20/20 to 20/200, within a few
months and then gradually decreases to no light per-
ception by the patient’s 50s or 60s.
A color-vision deficit occurs first in the blue-yellow
spectrum (tritanomalous defect) but rapidly becomes
complete. The visual fields initially demonstrate a rela-
tive central scotoma and constriction of the peripheral
field. This progresses to dense centrocecal scotoma and
marked constriction of the peripheral fields.
Fundus alterations begin with a decreased macular
reflex, a metallic sheen to the macula, and normal pe-
ripheral retina. This is followed by progressive atrophy
of the posterior neurosensory retina and of the retinal
pigment epithelium, with marked bone spicule pigment
in the peripheral retina, constriction of the retinal ar-
terioles, and a waxy pallor of the optic disk.
In younger patients, the light-adapted electroretino-
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Table 2
PCR Primer Sets for Amplification of SSCP Fragments of CRX
Amplified Fragment
(Size [in bp]) Primer Sequences
Size(s) Analyzed
(bp)
Exon 1 (257) 5′-CTGCACGTCACCCCATGGTGAGTAAC-3′ 257
5′-CAGAGGTCCTCCAAGAGATGAGGCC-3′
Exon 2 (314) 5′-GGATGGAATTCTTGGTCATCCCAC-3′ 178, 136a
5′-CTCTTTGTTCCGGGCAGGCCTC-3′
Exon 3a (501) 5′-CCAGCACCTCTCACCAATAAGTGTC-3′ 191, 174, 136a
5′-GGCGTAGGTCATGGCATAGG-3′
Exon 3b (294) 5′-CCTCCACAGATGTGTGTCCAGAC-3′ 294
5′-TGGGAGAAAGGTAGGGGTCTAGG-3′
Exon 3c (341) 5′-GCCTCCGCTTTCTGCTCTTC-3′ 209, 132a
5′-GCCCGATGGAGAGAGATGGAGACTG-3′
a Sizes after restriction digestion.
gram (ERG) is abnormal, but the scotopic ERG and the
electro-oculogram (EOG) are normal. Gradually, the
scotopic ERG and EOG become abnormal. Eventually,
the ERG becomes unrecordable at all frequencies and
intensities of stimulation in both light- and dark-adapted
states, and the EOG is markedly reduced.
Family RFS014, Cone-Rod Dystrophy.—The primary
visual disturbances in affected members of this family
are poor color vision and uncorrectable visual acuity,
which become evident by age 10 years and gradually
worsen with time. At age 25 years, the proband had a
best-corrected visual acuity of 20/50 OD and 20/200 OS
(lower OS acuity was attributed to refractive amblyo-
pia). Goldmann-Weekers dark-adapted thresholds (7
below fixation) were elevated by 0.3 log units. No field
defects were evident on screening perimetry. Full-field
ERGs revealed rod responses reduced by 50% and cone
responses reduced by 90%. At age 27 years, acuity was
further reduced to 20/160 OD and 20/320 OS, but no
further decline was evident in the ERG.
The best-corrected visual acuity in the father of the
proband, at age 54 years, was 20/200 OD and 20/250
OS. Goldmann-Weekers dark-adapted thresholds (7 be-
low fixation) were elevated by 0.2 log units. Full-field
ERGs revealed rod responses that were reduced by 85%
and cone responses that were reduced by 99%. The de-
ceased grandfather was thought to have had the same
problem and was known to have had low visual acuity
and color blindness prior to his death at age 59 years.
Family RFS087, Retinitis Pigmentosa (Late Onset with
Cone-Rod Involvement).—Affected patients in this fam-
ily were asymptomatic until their 50s or 60s. At age 58
years, the proband was found to have a temporal-field
defect in each eye, associated with pigment clumping in
the nasal periphery. Visual acuity was 20/15 OD and
20/20 OS. The dark-adapted threshold (7 below fixa-
tion) was elevated 0.2 log units. Rod ERG amplitudes
were 60% lower than normal, while cone ERGs to 30-
Hz flicker were reduced by 65%. The proband has
shown significant progression over 14 years of follow-
up. On the most recent visit, at age 72 years, visual acuity
was 20/600 OD and 20/900 OS, and the dark-adapted
threshold was elevated 0.8 log units. Both rod and cone
ERGs showed significant progression and were reduced
by 90%.
The proband’s father died at an early age, and nothing
is known about his visual status. The proband’s son was
asymptomatic at age 44 years, with visual acuity of 20/
20 in both eyes. Dark-adapted thresholds were normal.
Fluorescein angiography revealed slight peripheral gran-
ularity of the epithelium, without narrowing of vessels
or optic-nerve pallor. Rod ERG amplitudes were 50%
lower than normal, while cone ERGs to 30-Hz flicker
were reduced by 55%. Five years later, at age 49 years,
he had become aware of distortions and occasional blind
spots. Visual acuity was 20/20 OD and 20/25 OS, the
dark-adapted threshold was still normal, and full-field
ERGs did not show significant progression.
Family RFS900, Leber Congenital Amaurosis (Early-
Onset Retinitis Pigmentosa).—Affected members of this
family have severe visual disturbances in infancy, ac-
companied by nystagmus; some family members are se-
verely affected from birth, whereas other affected mem-
bers have partial vision into midlife (Heckenlively 1988).
The proband (IV:5 in fig. 4) was seen at age 27 years,
with best-corrected acuity of 20/300 OD and 20/80 OS.
His rod ERG was undetectable, and his cone ERG was
barely detectable (0.1 mV). His Humphrey field with spot
size 3 had an equivalent diameter of 6. His fundus
showed attenuated vessels, clumped pigment, and retinal
pigment epithelium atrophy, including the macula. At
age 11 years, his acuity was 20/200 OD and 20/60 OS.
His mother (III:3 in fig. 4) was seen at age 46 years.
She retains only light perception in each eye. Her rod
and cone ERG responses are undetectable. She was un-
able to see the most intense Goldmann-Weekers test tar-
get (elevated 16 log units) and was unable to perform
a visual field. She showed severe vessel attenuation, RPE
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Table 3
CRX Mutations and Sequence Variants in this Population
Codona Mutation cDNAb Phenotype
Family or
Frequency (%)
41 Arg41Gln (R41Q) G121A (CGGrCAG) Retinitis pigmentosa, auto-
somal dominant
RFS087
80 Glu80Ala (E80A) A238C (GAGrGCG) Cone-rod dystrophy, auto-
somal dominant
UTAD148
146 Leu146-12 (L146-12) 436del12 Leber congenital amaurosis,
autosomal dominant
RFS900
196 Ala1961 (A1961) 585insC (GCCrGCCC) Cone-rod dystrophy, auto-
somal dominant
RFS014
(83) IVS2-15GrA 253-15GrA Benign variant !.1
(34) IVS1-65ArT 101-65ArT Benign variant .2
183 Gly183Gly (G183G) G538A (GGG rGGA) Silent substitution !.1
199 Ser199Ser (S199S) C596T (TCCrTCT) Silent substitution !.1
a Parentheses around a codon indicate the nearest codon to an intronic sequence variant.
b cDNA sequence numbering based on GenBank accession number AF024711 (Freund et al. 1997), counting
the first nucleotide of the first codon as 1.
granularity, and patchy RPE atrophy (including a mac-
ular lesion) and has posterior cataracts. As determined
by her history, she had low vision from infancy. At age
30 years, her visual acuity was 2/200 OD and 20/200
OS, and her Goldmann visual field with the I-V isopter
was 8 OD and 12 OS.
The 30-year-old cousin of the proband (IV:1 in fig. 4)
also had only light perception in each eye. She had ex-
tremely low acuity and night blindness from early in-
fancy. Her rod and cone ERG responses were undetect-
able. She was unable to see the DA target (elevated 16
log units) and was unable to perform a visual field. Fun-
dus examination revealed severe vessel attenuation,
granularity of the RPE, and atrophy of both maculae.
Her daughter (V:3 in fig. 4) was seen at age 20 mo.
Her binocular visual acuity, measuredwith forced-choice
preferential looking, was 20/300. She had grossly ab-
normal rod sensitivity, determined by steady-state pup-
ilometry. She had nystagmus soon after birth, similar to
other affected family members. The posterior pole was
unremarkable, with the possible exception of slight ves-
sel attenuation.
Individual III:2 (fig. 4) was seen at age 49 years, with
no light perception in either eye. At age 35 years, she
was reported to have no light perception OD and barely
any light perception OS. Her fundus showed severe ves-
sel attenuation and diffuse RPE pigmentary distur-
bances, including macular atrophy.
The grandmother (II:2 in fig. 4) of the proband was
age 67 years at examination. She had no light perception
in either eye. She reported having visual difficulty, in-
cluding nystagmus, from infancy, although she could
read until age 15 years. On examination at age 52 years,
she was found to have barely any light perception in
each eye, posterior subcapsular cataracts, moderate ves-
sel attenuation, and diffuse RPE atrophy.
Discussion
Previous studies associated mutations in theCRX gene
sequence with cone-rod dystrophy and de novo Leber
congenital amaurosis (Freund et al. 1997; Swain et al.
1997; Freund et al. 1998). We now extend the range of
phenotypes that may result from mutations in CRX to
include dominant retinitis pigmentosa and dominant Le-
ber congenital amaurosis. A diagram of the known dis-
ease-associated mutations in CRX is shown in figure 5.
Thus, like those in peripherin/RDS, mutations in CRX
are associated with several forms of retinal degeneration.
In a survey of 294 unrelated affected individuals from
families with various forms of inherited retinopathy, we
found four disease-associated mutations in CRX. These
mutations were not observed in any of the other unre-
lated individuals screened, a total of 588 chromosomes,
nor in other published CRX surveys, except in associ-
ation with inherited retinopathy. Thus, CRX mutations
are a rare but significant cause of inherited retinal dis-
eases.
Are these four CRX mutations the cause of disease in
the families in which they are found? The Glu80Ala
(E80A) mutation found in the family with autosomal
dominant cone-rod dystrophy, UTAD148, is segregating
with the disease phenotype in 35 informative family
members; the disease locus is also tightly linked to the
CORD2 locus on 19q13 (Sohocki et al. 1997). The
E80A mutation was previously reported in another large
family with cone-rod dystrophy (Freund et. al 1997),
although haplotype analysis shows that the mutations
are of independent origin. This mutation falls in the
recognition helix of the homeodomain in the CRX pro-
tein and may be involved in dimerization (Freund et al.
1997). The change of a glutamic acid residue to an al-
anine is likely to disrupt the salt bridge between residues
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Figure 5 Disease-associated mutations within CRX. Nucleotide numbering of the cDNA begins with the A of the ATG start codon,
assigned as position 1. Mutations reported in this article are listed above the cDNA diagram, and previously reported mutations are listed
below the cDNA diagram. a  reported in Freund et al. 1997, b  reported in Swain et al. 1997, and c  reported in Freund et al. (1998).
R69 and E80, probably causing a loss of function
(Freund et al. 1997). For these reasons, it is highly likely
that this is the cause of disease in both families.
The 1-bp insertion (A1961) found in RFS014, the
second family in this series with dominant cone-rod dys-
trophy, is present in four affected individuals. The in-
sertion causes a frameshift leading to 39 altered amino
acids, followed by a premature stop codon. The result
of the stop codon is a protein truncated by 22%, lacking
the conserved OTX tail. This mutation is likely to cause
loss of function and to lead to the disease seen in this
family.
The Arg41Gln (R41Q) mutation is found in three af-
fected family members and is absent from one unaffected
at-risk member of RFS087, a family with autosomal
dominant retinitis pigmentosa. The same mutation was
reported previously in a family with cone-rod dystrophy
(Swain et al. 1997); clinical details have not been pub-
lished. The clinical phenotype in RFS087 is consistent
with late-onset retinitis pigmentosa or mild, atypical,
cone-rod dystrophy, but a direct clinical comparison of
the two families is necessary in order to determine
whether they actually differ in phenotype. Substitution
of a tryptophan for the arginine at codon 41 produces
a recombinant CRX homeodomain with reduced bind-
ing activity for the rhodopsin promoter (Swain et al.
1997). Since the substitution of glutamine for arginine
at this site causes a nonconservative change in net
charge, this mutant CRX protein may also affect pro-
motor activity. For these reasons, this mutation is likely
to be the cause of the clinical phenotype in both families.
Finally, the 12-bp deletion (L146-12) found in the
family with dominant Leber congenital amaurosis,
RFS900, has not been reported previously. Themutation
was observed in six affected family members. The mu-
tation results in an in-frame deletion of residues 147–
150. (The codon for residue 146, a leucine, is also af-
fected, but the resulting triplet still codes for leucine.)
These four amino acids are also present in the mouse
Crx protein. Such a substantial deletion is likely to affect
the function of the CRX protein. For these reasons, this
mutation is likely to be the cause of the clinical phe-
notype in this family.
The four CRXmutations found in this survey account
for a wide range of clinical phenotypes. The E80A mu-
tation is found in families with classic, dominant cone-
rod dystrophy, including symptoms by age 8 years, color-
vision deficits, and early cone involvement followed by
rod involvement in later years. The A1961 mutation
is associated with a progressive loss of visual acuity that
begins in the 1st decade of life. This mutation produces
a cone-rod pattern of progressive retinal degeneration,
but patients retain both rod and cone ERG responses
well into the 5th decade. The R41Qmutation was found
in one family, RFS087, with an initial diagnosis of au-
tosomal dominant retinitis pigmentosa. Although pa-
tients in this family were thought to have retinitis pig-
mentosa on the basis of fundus appearance, affected
family members are asymptomatic until their 50s or 60s,
retain detectable rod ERG responses at least into their
70s, and have comparable loss of rod and cone ERG
responses. The L146-12 mutation is associated with a
more severe retinal dystrophy that shares many of the
characteristics of Leber congenital amaurosis, including
an undetectable ERG in the 1st decade of life.
Mutations in CRX are associated with clinical char-
acteristics of cone-rod dystrophy, dominant retinitis pig-
mentosa, or dominant Leber congenital amaurosis.
Different CRX mutations may produce significantly dif-
ferent retinal disease phenotypes, and these diseases also
have significantly different ages at onset. Thus, muta-
tions in CRX, a transcriptional activator of several ret-
inal genes, may be associated with congenital, early-on-
set, or late-onset retinal degeneration.
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